SCHEMBL4345397

SCHEMBL4345397

O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cccc(F)c1O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.58
DHODH Q02127 1/20 0.57
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
MAPT P10636 5/20 0.55
RAB9A P51151 5/20 0.55
NPSR1 Q6W5P4 1/20 0.55
LMNA P02545 3/20 0.54
HTT P42858 3/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 3/20 0.51
NPC1 O15118 3/20 0.51
GRIK1 P39086 2/20 0.50
GAA P10253 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
P2RY1 P47900 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
FBP1 P09467 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430664 0.87 DHODH (0.58) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL4346986 0.87 NPC1 (0.56) TRPV1MEN1KMT2AMAPTRAB9A
SCHEMBL4356208 0.85 TRPV1 (0.60) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL4344050 0.82 MAOB (0.56) MEN1KMT2AMAPTNPSR1LMNA
SCHEMBL23831818 0.82 DHODH (0.53) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL30105254 0.82 DHODH (0.53) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL4348999 0.81 KMT2A (0.70) TRPV1MEN1KMT2AMAPTRAB9A
SCHEMBL7105392 0.81 MEN1 (0.76) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL4350046 0.81 MEN1 (0.49) TRPV1DHODHMEN1KMT2AMAPT
SCHEMBL6227015 0.81 MEN1 (0.71) TRPV1MEN1KMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 TRPV1 2328/4885DHODH 3280/4885MEN1 2168/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 TRPV1 2320/4885DHODH 2230/4885MEN1 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.